Eli Lilly (LLY)

• Market cap: $939B
• 1 day: 1.9%
• 5 days: 3.91%
• 1 month: 29.75%
• 3 months: 49.26%
• 6 months: 39%
• Year to date: 34.9%
• 1 year: 43.83%
• 5 years: 631.89%
• 10 years: 1,153.7%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 47,000